| Basic Medical Informatin |
| brand name |
| Razadyne, Razadyne Er, Reminyl, Nivalin |
Zoloft |
| Treatment For |
| Mild To Moderate Dementia Caused By Alzheimer's Disease |
Depression, Obsessive-compulsive Disorder, Panic Disorder, Anxiety Disorders, Post-traumatic Stress Disorder (ptsd), And Premenstrual Dysphoric Disorder (pmdd) |
| Legal Status |
| Rx-only |
Rx-only |
| Pregnancy cat. |
| B (us) |
C (us) |
| Possible Side Effects |
| Diarrhea; Dizziness; Headache; Indigestion; Loss Of Appetite; Mild Stomach Pain Or Upset; Nausea; Tiredness; Trouble Sleeping; Vomiting; Weight Loss. |
Fever, Sweating, Confusion, Fast Or Uneven Heartbeats, Agitation, Hallucinations, Fever, Overactive Reflexes, Tremors, Nausea, Vomiting, Diarrhea, Loss Of Appetite, Feeling Unsteady, Loss Of Coordination, Or Headache, Trouble Concentrating, Memory Problems, Weakness, Fainting, Seizure, Shallow Breathing |
| Precautions & Contraindications |
| Pregnant, Liver Or Kidney Problems, Heart Problems, Unexplained Fainting Episodes, Stomach Or Bowel Problems, Lung Or Breathing Problems, Copd, Or Urinary Blockage Or Trouble Urinating, Brain Lesions Or Tumors, Dementia |
Hypomania And Seizure Disorders, Liver Or Kidney Damage, Heart Disease, Recent Heart Attack, Bleeding Disorders, Diabetes And Angle-closure Glaucoma |
| Excretion |
| Renal (95%, Of Which 32% Unchanged), Fecal (5%) |
Renal |
| Storage Conditions |
| Room Temperature, In An Airtight Container. Keep Away From Children |
15-30°c |
|
| Dosage, Usage and Forms |
| Forms |
| Tablet, Capsule |
Tablet |
| Routes (of administration) |
| Oral |
Oral |
|
Dosage |
|
50 mg |
| Chemical Data |
| Bioavailability |
| 80-100% |
44 % |
| Protein binding |
| Hepatic, 18% |
99 % |
| Metabolism |
| Hepatic Partially |
Hepatic |
| Half Life (hours) |
| 7 h |
Approximately 26 H |
| Formula |
| C17h21no3 |
C17h17cl2n |
| Molecular mass (g/mol) |
| 287.354 G/mol |
306.229 G/mol |